24.01.2013 • News

Lanxess Expands Dichlorobenzene Capacity by 15% at Leverkusen Facility

Specialty chemicals company Lanxess has increased its dichlorobenzene capacity by more than 15%. It has done so by installing an additional crystallizer at the Leverkusen site, thereby enabling it to produce more high-purity para-dichlorobenzene for the global market.

Some €3 million has been invested in the capacity expansion for this intermediate for the manufacture of high-performance plastics.

 

From Catalogue to Collaboration

Enamine's Expert Insights Collection Is Free to Download
Enamine’s 35 Years of Advancing Drug Discovery

Enamine's Expert Insights Collection Is Free to Download

From catalogue to collaboration — explore 35 years of drug discovery breakthroughs, novel building blocks, and the science shaping tomorrow's medicines. Download your complimentary copy now.

Expert Insights

ADCs for Precision Cancer Therapy
Comprehensive Insights into Antibody–Drug Conjugates

ADCs for Precision Cancer Therapy

Explore how antibody-drug conjugates are reshaping precision cancer therapy and discover what it takes to successfully develop, manufacture, and scale these complex biologics.

most read

Photo

VCI Welcomes US-EU Customs Deal

The German Chemical Industry Association (VCI) welcomes the fact that Ursula von der Leyen, President of the European Commission, and US President Donald Trump have averted the danger of a trade war for the time being.